Botulinum Antitoxin Heptavalent (2026)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract, identified by solicitation number C459163, is an award notice issued by the Secretary of State for Health and Social Care acting through the UK Health Security Agency for the supply of Botulinum Antitoxin Heptavalent. The agreement was awarded to Emergent BioSolutions Canada Inc, falling under NAICS code 325414. The contract is estimated to run from November 16, 2026, to November 15, 2028, with the possibility of extensions continuing through 2030. Administrative inquiries regarding this procurement are managed by the Commercial Preparedness and Medical Countermeasures department.
General Info
Contract Value
$0Place of Performance
GBRSet-Aside
Awardee
Emergent BioSolutions CanadaAward Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
